COPENHAGEN (Reuters) - Danish pharmaceutical group Lundbeck has filed an appeal against a 93.8 million euros ($123.7 million) fine by the European Commission for deals with rivals to block the supply of generic versions of its citalopra anti-depressant to the market. Lundbeck said in a statement that the aim of the appeal was to have the decision annulled or the fine reduced. The company said it expects a decision on the appeal within two to three years. ($1 = 0.7584 euros) (Reporting by Copenhagen Newsroom; Editing by David Goodman) via Health News Headlines - Yahoo! News Read More Here..
No comments:
Post a Comment